Assessment of Cancer Therapy Evaluation Program Advocacy and Inclusion Rates of People Living With HIV in Anti–PD1/PDL1 Clinical Trials-Reference-Cited by-同舟云学术

Assessment of Cancer Therapy Evaluation Program Advocacy and Inclusion Rates of People Living With HIV in Anti–PD1/PDL1 Clinical Trials

Published:2020-12-01 Issue:12 Volume:3 Page:e2027110
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Reuss Joshua E.¹,Stern Diana²,Foster Jared C.³,Ramaswami Ramya⁴,Lurain Kathryn⁴,Chen Helen X.⁵,Streicher Howard⁵,Kem Ravie⁵,Little Richard F.⁵,Sharon Elad⁵

Affiliation:

1. Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC

2. Yale New Haven Health System, Bridgeport, Connecticut

3. Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland

4. HIV/AIDS Malignancy Branch, National Cancer Institute, Center for Cancer Research, Bethesda, Maryland

5. Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2773341/reuss_2020_oi_200874_1606759118.41551.pdf

Reference17 articles.

1. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.;Samji;PLoS One,2013

2. Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030.;Shiels;Ann Intern Med,2018

3. Cumulative incidence of cancer among persons with HIV in North America: a cohort study.;Silverberg;Ann Intern Med,2015

4. Lung cancer mortality associated with smoking and smoking cessation among people living with HIV in the United States.;Reddy;JAMA Intern Med,2017

5. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.;Brahmer;N Engl J Med,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer in People with HIV;Infectious Disease Clinics of North America;2024-09

2. Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States;Clinical Lymphoma Myeloma and Leukemia;2024-08

3. Reflecting the Real World of Cancer Care — The Impact of Broadening Trial Eligibility;NEJM Evidence;2024-03-26

4. A clinical overview of people living with HIV and genitourinary cancer care;Nature Reviews Urology;2024-01-18

5. Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium;Journal of Clinical Oncology;2023-07-20